Tag: Ultragenyx Pharmaceutical

By Posted on Posted in Fundamental Valuation Report

Fundamental Valuation Report Mirati Therapeutics(MRTX:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$144.00 (USD) 05/07/2021 Weighted Valuation$148.78 (USD) Overall RatingFairly valued to slightly Undervalued by 3.3% Valuation Models Comparables: $165.51 …

Mirati Therapeutics (MRTX:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Fundamental Valuation Report

Fundamental Valuation Report BridgeBio Pharma(BBIO:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$55.12 (USD) 04/16/2021 Weighted Valuation$37.29 (USD) Overall RatingOvervalued by 32.3% Valuation Models Comparables: $37.29 (USD) Valuation Methods …

BridgeBio Pharma (BBIO:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Uncategorised

Fundamental Valuation Report Array BioPharma(ARRY:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$17.53 (USD) 18/01/2019 Weighted Valuation$23.36 (USD) Overall RatingUndervalued by 33.2% Valuation Models Analyst Consensus: $30.00 (USD) (in …

Array BioPharma (ARRY:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Uncategorised

Fundamental Valuation Report Array BioPharma(ARRY:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$13.70 (USD) 24/10/2018 Weighted Valuation$22.50 (USD) Overall RatingUndervalued by 64.3% Valuation Models Analyst Consensus: $26.00 (USD) (in …

Array BioPharma (ARRY:NAS) Fundamental Valuation Report Read more »

Read More